Involvement of G protein-coupled receptor kinase 4 and 6 in rapid desensitization of dopamine D1 receptor in rat IEC-6 intestinal epithelial cells

Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R772-9. doi: 10.1152/ajpregu.00208.2004. Epub 2004 May 27.

Abstract

Dopamine-induced inhibition of Na(+)-K(+)-ATPase has been suggested to play a role in the regulation of Na(+) absorption at the intestinal level, and these effects were mediated by dopamine D(1)-like receptors. The aim of this work was to evaluate the effect of the activation of the D(1)-like receptors on the activity of the Na(+)/H(+) exchanger (NHE) in the rat intestinal epithelial cell line IEC-6. The presence of D(1) receptors was confirmed by immunoblotting. The dopamine D(1)-like receptor agonist SKF-38393 produced a concentration-dependent inhibition of NHE activity and stimulation of adenylyl cyclase (AC), this being antagonized by the D(1) selective antagonist SKF-83566. Effects of SKF-38393 on NHE and AC activities were maximal at 5 min of exposure to the agonist and rapidly diminished with no effect at 25 min. Exposure of cells for 25 min to dibutyryl-cAMP (0.5 mM) or to the AC activator forskolin (3 microM) effectively inhibited NHE activity. Pretreatment of cells with heparin (1 microM), a nonselective G protein-coupled receptor kinase (GRK) inhibitor, prevented the loss of effects on NHE activity after 25 min exposure to SKF-38393. The presence of GRK4, GRK6A, and GRK6B was confirmed by immunoblotting. Overnight treatment with the anti-GRK4-6 antibody complexed with Lipofectin was also effective in preventing loss of the effects of SKF-38393 on NHE and AC activities. It is concluded that dopamine D(1) receptors in IEC-6 rapidly desensitize to D(1)-like agonist stimulation and GRK4 and 6 appear to be involved in agonist-mediated responsiveness and desensitization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / analogs & derivatives*
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Adenylyl Cyclases / metabolism
  • Animals
  • Antibodies, Blocking / pharmacology
  • Blotting, Western
  • Cell Line
  • Cyclic AMP / physiology
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Dopamine Agonists / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / physiology*
  • G-Protein-Coupled Receptor Kinase 4
  • G-Protein-Coupled Receptor Kinases
  • Heparin / pharmacology
  • Intestines / cytology
  • Intestines / physiology*
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • Isoenzymes / physiology
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Rats
  • Receptors, Dopamine D1 / agonists
  • Receptors, Dopamine D1 / physiology*
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors
  • Sodium-Hydrogen Exchangers / metabolism

Substances

  • Antibodies, Blocking
  • Dopamine Agonists
  • Enzyme Inhibitors
  • Isoenzymes
  • Receptors, Dopamine D1
  • Sodium-Hydrogen Exchangers
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Heparin
  • 1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-
  • Cyclic AMP
  • Protein Serine-Threonine Kinases
  • Cyclic AMP-Dependent Protein Kinases
  • G-Protein-Coupled Receptor Kinase 4
  • G-Protein-Coupled Receptor Kinases
  • G-protein-coupled receptor kinase 6
  • Grk4 protein, rat
  • Adenylyl Cyclases